 longevity,
potential needs for late rescreening,263 and selective
screening to optimize yield at minimal cost.264 Reducing

all-cause mortality and enhancing yield might be
increased by integrating AAA screening with concurrent
echocardiography265 or blood pressure and peripheral
vascular disease testing.266 Ensuring full participation
for all groups of patients at risk remains an ever-present
challenge.267,268
We recommend a